<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Typical blood smear findings in selected hemolytic anemias</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Typical blood smear findings in selected hemolytic anemias</h1>
<div class="graphic"><div class="figure"><div class="ttl">Typical blood smear findings in selected hemolytic anemias</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Hemolytic anemia</td> <td class="subtitle1">Typical blood smear findings</td> </tr> <tr> <td class="subtitle2_left divider_bottom" colspan="2">Acquired</td> </tr> <tr> <td class="indent1">Autoimmune hemolytic anemia</td> <td>Spherocytes (some), microspherocytes</td> </tr> <tr> <td class="indent1">Clostridial (or other fulminant bacterial) sepsis</td> <td>RBC ghosts</td> </tr> <tr> <td class="indent1">Cold agglutinin disease</td> <td>RBC clumps</td> </tr> <tr> <td class="indent1">Drug-induced hemolysis</td> <td>Nonspecific findings</td> </tr> <tr> <td class="indent1">Hemolytic transfusion reaction</td> <td>Nonspecific findings or some spherocytes</td> </tr> <tr> <td class="indent1">Microangiopathic hemolytic anemia (MAHA; eg, as in TTP, HUS, or DIC)</td> <td>Schistocytes (may be less abundant in DIC)</td> </tr> <tr> <td class="indent1">RBC parasite (eg, malaria, <em>Babesia</em>)</td> <td>Intracellular parasitic ring forms (especially on thick smear)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Inherited</td> </tr> <tr> <td class="indent1">Alpha thalassemia</td> <td>Microcytic and hypochromic cells (can be profound in severe disease), target cells, microspherocytes, basophilic stippling</td> </tr> <tr> <td class="indent1">Beta thalassemia</td> <td>Microcytic and hypochromic cells (can be profound in severe disease), target cells, teardrop cells, RBC fragments, basophilic stippling</td> </tr> <tr> <td class="indent1">G6PD deficiency</td> <td>Bite cells, nonspecific findings</td> </tr> <tr> <td class="indent1">Hemoglobin C disease</td> <td>Hemoglobin crystals</td> </tr> <tr> <td class="indent1" colspan="2">Hereditary elliptocytosis</td> </tr> <tr> <td class="indent2"> <ul> <li>Classic hereditary elliptocytosis </li> <li>Hereditary pyropoikilocytosis </li> <li>Southeast Asian ovalocytosis </li> </ul> </td> <td> <ul> <li>Elliptocytes/ovalocytes </li> <li>Spherocytes, elliptocytes, microcytes </li> <li>Stomatocytic elliptocytes </li> </ul> </td> </tr> <tr> <td class="indent1">Hereditary spherocytosis</td> <td>Spherocytes (abundant)</td> </tr> <tr> <td class="indent1">Hereditary stomatocytosis</td> <td>Stomatocytes (cells with a mouth-shaped area of central pallor), may be as high as 40 to 60%</td> </tr> <tr> <td class="indent1">Hereditary xerocytosis</td> <td>Xerocytes (hyperchromic misshapen cells with hemoglobin puddled at the periphery), target cells</td> </tr> <tr> <td class="indent1">Pyruvate kinase deficiency</td> <td>Nonspecific findings, echinocytes</td> </tr> <tr> <td class="indent1">Sickle cell disease</td> <td>Sickle cells, Howell-Jolly bodies</td> </tr> </tbody></table></div><div class="graphic_lgnd">Typical findings are listed for each of the conditions; some patients may have other findings depending on their clinical status (eg, concomitant deficiency of vitamin B12, folate, copper, or iron; concomitant myelodysplasia; concomitant renal or hepatic insufficiency). Nonspecific findings include polychromatophilia, due to reticulocytosis (present in all individuals with hemolytic anemia who have a bone marrow response). Other general findings in hemolytic anemia include increased reticulocyte count (unless the bone marrow is unable to respond), as well as serum markers of hemolysis (eg, increased LDH, increased indirect bilirubin, low haptoglobin). Refer to UpToDate for details of the evaluation and clinical features.</div><div class="graphic_footnotes">RBC: red blood cell; MAHA: microangiopathic hemolytic anemia; TTP: thrombotic thrombocytopenic purpura; HUS: hemolytic uremic syndrome; DIC: disseminated intravascular coagulation; G6PD: glucose-6-phosphate dehydrogenase; LDH: lactate dehydrogenase.</div><div id="graphicVersion">Graphic 116947 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
